LAMTOR1 degrades MHC-II via the endocytic in hepatocellular carcinoma

Tumor cell surface antigen recognition is a major hallmark of cancer therapy, and loss of major histocompatibility complex class I (MHC-I) is the most common mechanism that impairs tumor cell surface antigen processing and expression. In addition to this, MHC-II regulates antigen presentation in CD4...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bo, Wang, Qian, Li, Bowen, Jiang, Meixi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Carcinogenesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890926/
https://www.ncbi.nlm.nih.gov/pubmed/36070764
http://dx.doi.org/10.1093/carcin/bgac075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890926/
https://www.ncbi.nlm.nih.gov/pubmed/36070764
http://dx.doi.org/10.1093/carcin/bgac075

Ejemplares similares